Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Israel and the occupied territories: ICRC facilitates voluntary return of 88 individuals to Gaza
International Committee of the Red Cross
At the request and with the agreement of relevant authorities, the ICRC transferred the individuals from Kerem Shalom crossing to Nasser Medical Complex in Gaza. Our team also facilitated their communication with families as needed.
ENvue Medical Moves NanoVibronix Manufacturing to the United States, Consolidates R&D in Tel Aviv, Israel, Increasing Operational Efficiencies and Cost Reduction Opportunities
GlobeNewswire, Inc.
TYLER, Texas, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue” or the “Company”), a commercial-stage medical device company, today announced it has completed the transition of its NanoVibronix manufacturing operations...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alignment Healthcare, Inc. - ALHC
GlobeNewswire, Inc.
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Alignment Healthcare, Inc. (“Alignment” or the “Company”) (NASDAQ: ALHC). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA
GlobeNewswire, Inc.
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. (“HCA” or the “Company”) (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc. - IONS
GlobeNewswire, Inc.
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ionis Pharmaceuticals, Inc. (“Ionis” or the “Company”) (NASDAQ: IONS). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
GlobeNewswire, Inc.
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. (“Agios” or the “Company”) (NASDAQ: AGIO). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – REGN
GlobeNewswire, Inc.
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN). Such investors are advised to contact Danielle...
ONE•Beauty Space Introduces the Matrix® Skin Renewal Platform: A Revolutionary Approach to Skin Health
EIN Presswire
BROOKLYN, NY, UNITED STATES, August 4, 2026 /EINPresswire.com/ -- ONE•Beauty Space is proud to announce the addition of the Candela Matrix® platform to its comprehensive suite of aesthetic services.
Sofwave Medical Reports Second Quarter and First Half 2026 Financial Results and Business Highlights
GlobeNewswire, Inc.
Second quarter revenue of $30M, +43% year-over-year growth; IFRS gross margin of 76.5% Second quarter usage fee revenue of $13.9M, 52.2% year-over-year growth First half revenue of $54.4M, +44% year-over-year growth; IFRS gross margin of 75.8%...
SciSparc: Subsidiary NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome
GlobeNewswire, Inc.
TEL AVIV, Israel, Aug. 05, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel...
Quantum X-Labs Advances Quantum Computing for Nuclear Particle Transport prediction
GlobeNewswire, Inc.
The technology aims to translate the physical transport model into a quantum circuit Tel Aviv, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Quantum X Labs Inc. (Nasdaq: QXL) (“Quantum X” or the “Company”), an advanced technologies company, today announced...
BiomX Acquires 10% Stake in Motomea, Inventor of Advanced Electric Motor Technologies for Drone and Autonomous Systems
GlobeNewswire, Inc.
NETANYA, Israel, Aug. 05, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a defense technology company building a portfolio of technologies to detect, analyze and respond to physical threats, today announced...
Kamada to Announce Second Quarter and First Half Ended June 30, 2026 Financial Results on August 12, 2026
GlobeNewswire, Inc.
REHOVOT, Israel, and HOBOKEN, N.J., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the...
UroGen Reports $50.4 Million of ZUSDURI Revenue and Provides Second Quarter 2026 Financial Results and Highlights
GlobeNewswire, Inc.
ZUSDURI® generated $50.4 million in revenue in the second quarter of 2026, representing 73% quarter-over-quarter growth Once issued, new U.S. patent is expected to provide protection into July 2044 for ZUSDURI and UGN-103 Continued advancement of...
Silexion Therapeutics Successfully Initiates Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer at Tel Aviv Sourasky Medical Center
GlobeNewswire, Inc.
Successful initiation of the Phase 2/3 clinical trial of SIL204 at Tel Aviv Sourasky Medical Center (“TASMC” or “Ichilov”), one of Israel’s largest and most prominent academic medical centers, clears the site to commence patient screening...
Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton
GlobeNewswire, Inc.
Ottobock Care, one of the leading mobility technology patient care organizations in the U.S., brings extensive clinical expertise and patient care infrastructure Advances Lifeward’s strategy to broaden ReWalk access through capital-efficient...
Merit Medical Reports Second Quarter 2026 Results And Updates Full-Year 2026 Guidance
GlobeNewswire, Inc.
Financial Highlights† Reported revenue of $418.8 million, up 10% Constant currency revenue* and constant currency revenue, organic* up 9% and up 9%, respectively GAAP operating margin of 14.4%, compared to 12.3% in prior year period Non-GAAP...
Assured Raises $19M Series A Led by Insight Partners to Automate Healthcare Provider Operations with AI Agents
GlobeNewswire, Inc.
NEW YORK, July 30, 2026 (GLOBE NEWSWIRE) -- This funding accelerates Assured’s mission to replace manual healthcare provider operations with AI agents, so providers get onboarded faster and patients receive care sooner.
UroGen Pharma to Report Second Quarter 2026 Financial Results on Wednesday, August 5th, 2026
GlobeNewswire, Inc.
PRINCETON, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will...
123rd Medical Group and Kentucky Guard Airmen honored for national excellence
DVIDS - Georgia
The Kentucky Air National Guard’s 123rd Medical Group has been named Air National Guard Medical Unit of the Year, and two of its officers have been recognized for individual excellence in the 2025 Air National Guard Medical Service Awards.
Sign up for:
Israel Healthcare News
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.